Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
|ClinicalTrials.gov Identifier: NCT03587324|
Recruitment Status : Completed
First Posted : July 16, 2018
Last Update Posted : July 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Vascular Surgery Patient With PAD / Carotid Stenosis||Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||176 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Perioperative Risk Factors for the Development of Aspirin Low Response in Patients Undergoing Vascular Surgery.|
|Actual Study Start Date :||February 2013|
|Actual Primary Completion Date :||March 2015|
|Actual Study Completion Date :||March 2015|
Experimental: Experimental: aspirin, clopidogrel
Perioperative measurement of ASA and clopidogrel resistance in patients undergoing vascular treatment
Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).
To identify possible risk factors demographic data, concomitant medication, laboratory parameters, co-morbidities, severity of the condition and the type of procedure performed are documented.
Other Name: ASA (aspirin), Clopidogrel (Plavix)
- Number of Participants Who Were Responders or Low-Responders of Antiplatelet Therapy as a Result of Whole Blood Aggregometry Testing [ Time Frame: 2 years ]In patients treated with aspirin and clopidogrel aggregometry was performed and depending on the results the patients were either responder or low-responder of antiplatelet therapy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03587324
|Department of vascular surgery, St. Josef Hospital, Ruhr University of Bochum|
|Bochum, NRW, Germany, 44791|